Insider Transactions in Q3 2021 at Akero Therapeutics, Inc. (AKRO)
Insider Transaction List (Q3 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 15
2021
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
12,500
-4.34%
|
$300,000
$24.94 P/Share
|
Sep 02
2021
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
17,500
-5.37%
|
$402,500
$23.89 P/Share
|
Sep 01
2021
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,559
-72.31%
|
$205,416
$24.0 P/Share
|
Sep 01
2021
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,559
+41.97%
|
$59,913
$7.01 P/Share
|
Sep 01
2021
|
Jonathan Young Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
12,500
-7.23%
|
$300,000
$24.04 P/Share
|
Aug 16
2021
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
10,000
-6.41%
|
$180,000
$18.79 P/Share
|
Aug 03
2021
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
17,500
-2.55%
|
$367,500
$21.15 P/Share
|
Aug 02
2021
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,441
-57.54%
|
$97,702
$22.03 P/Share
|
Aug 02
2021
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,441
+36.52%
|
$31,087
$7.01 P/Share
|
Jul 15
2021
|
Jonathan Young Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+4.94%
|
$0
$0.62 P/Share
|
Jul 15
2021
|
Catriona Yale Chief Development Officer |
SELL
Open market or private sale
|
Direct |
10,000
-6.03%
|
$200,000
$20.9 P/Share
|
Jul 06
2021
|
William Richard White Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,500
-66.48%
|
$156,000
$24.52 P/Share
|
Jul 06
2021
|
William Richard White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+39.93%
|
$45,500
$7.01 P/Share
|
Jul 02
2021
|
Andrew Cheng President and CEO |
SELL
Open market or private sale
|
Direct |
17,500
-4.86%
|
$420,000
$24.78 P/Share
|